1. Activators of Rho GTPases for the treatment of cognitive and learning disorders
2. N-acetyl-D-mannosamine for the treatment of brain hypofunction
3. Protein cross-linking inhibitor for the treatment of neurodegenerative diseases
4. New PDE9A inhibitors for the treatment of Alzheimer’s disease
5. Proteosome-based adjuvant for the treatment of cerebral amyloid angiopathy

1. Inhibitors of t-RNA and 28s rRNA for the treatment of chronic lymphocytic leukemia (CLL)
2. Compounds that inhibits expression of iNOS and COX-2 without inhibiting NF-kappa B
3. Small molecule choline kinase inhibitors for the treatment of cancer
4. Matrix metalloproteinase derived peptides for the treatment of melanoma and breast cancer
5. siRNA targeting heterogeneous nuclear ribonucleoprotein K expression for the treatment of cancer
6. Mitochondria targeted rosamine derivatives for the treatment of cancer
7. Combination of ZD6474 and pemetrexed for the treatment of solid tumors
8. Combination of P70S6 kinase inhibitor and mTOR inhibitor for the treatment of cancer
9. siRNA targeting the CYCLIN D1/TROP2 chimeric mRNA for the treatment of cancer
10. Nanoparticles for the enhancement of radiotherapy efficacy in cancer patients
11. Cancer vaccine formulation using PASD1-derived peptides

Drug delivery patents

1. Enhanced topical delivery of siRNA
2. Iontophoretic patch for the treatment of migrane
3. Magnetic nanodelivery of therapeutic agents across the blood brain barrier for the treatment of CNS disorders

Herbal drug patents

1. Brazilin for the treatment of allergic diseases and allergic asthma
2. Herbal extract with liver-X-receptor modulators for the treatment of obesity

Obesity drug patents

1. Lipoprotein lipase as a drug target of obesity
2. Enterostatin for the treatment of obesity
3. Small molecule ghrelin O-acyltransferase (GOAT) inhibitors for the treatment of obesity